Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 5 April

Sophia Mavridis
April 5, 2022

Morning Bell 4 April

Sophia Mavridis
April 4, 2022

Weekly Wrap 1 April

Sophia Mavridis
April 1, 2022

Morning Bell 31 March

Paulina Peters
March 31, 2022

Morning Bell 30 March

Sophia Mavridis
March 30, 2022

Morning Bell 29 March

Paulina Peters
March 29, 2022

Morning Bell 28 March

Sophia Mavridis
March 28, 2022

Weekly Wrap 25 March

Sophia Mavridis
March 25, 2022

Morning Bell 24 March

Sophia Mavridis
March 24, 2022

Morning Bell 23 March

Paulina Peters
March 23, 2022

Morning Bell 22 March

Paulina Peters
March 22, 2022